I am posting an email from Aubrey deGrey’s Strategies for Engineered Senescence (SENS.) I attended the 2008 meeting at UCLA ( see http://www.sens.org/ADCI/ and it was simply amazing.
If you have a science background and can make it, you will not be disappointed!
In fact, that is where I learned that we are always making 10,000 new brain cells a day. Ask any physician and they will regurgitate the dogma that we don’t make new neurons. How wrong could we be for so wrong for so long? Find out what else you don’t know at www.rechargebiomedical.com/aging.html
My apologies if you receive this email more than once (or if you have already registered!). Please forward it to any colleagues who you feel may be interested.
I am writing to remind you that THIS COMING MONDAY, June 15th, is the deadline for discounted registration and abstract submission for the fourth Strategies for Engineered Negligible Senescence (SENS) conference, to be held at Queens’ College, Cambridge, England on September 3rd-7th 2009. After the deadline, both student and standard registration fees rise by £150.00. Also, after that date, we cannot guarantee that submitted abstracts will be considered for oral presentation or that they will be included in the conference abstract book.
All details of the conference, including forms for abstract submission and online registration, are at the conference website:
The conference program features 45 confirmed speakers, all of them world leaders in their field. As with previous SENS conferences, the emphasis of this meeting is on “applied gerontology” – the design and implementation of biomedical interventions that may, jointly, constitute a comprehensive panel of rejuvenation therapies, sufficient to restore middle-aged or older laboratory animals (and, in due course, humans) to the physical and mental robustness of young adults. The list of sessions and confirmed speakers is as follows:
- Moses Znaimer, media mogul and founder of the Canadian Association for Retired Persons
- Combating oxidation:
Vladimir Skulachev, Holly Brown-Borg, James Joseph, Cathy Clarke
- Optmising metabolism against aging:
Stephen Spindler, Stephen Vatner, Rafael de Cabo, David Melzer
- Adult regenerative capacity:
Brandon Reines, Jonathan Tilly, Alexandra Stolzing
- Eliminating recalcitrant intracellular molecules:
William Sly, Ana Maria Cuervo, John Schloendorn, Claude Wischik
- Rejuvenating extracellular material:
Nik Nikitin, Mark Pepys, Sudhir Paul, Mark Noble, Roberta Cortivo, Kendall Houk
- Novel anti-cancer approaches:
Paul Hallenbeck, Adela Ben-Yakar, Cassian Yee
- Telomeres and telomerase:
Vera Gorbunova, Maria Blasco, David Keefe
- Rejuvenating the immune system:
Janko Nikolich-Zugich, Anne de Groot, Omar Ali
- Delivering large structures in vivo:
Pin Wang, Lusine Danielyan, Carlos Barbas
- ES-like cells and cell therapy:
Justin Ichida, Ilham Abuljadayel, Thomas Zwaka, Daniel Kraft, John Sladek, Dan GazitM/
- Tissue engineering:
Augustinus Bader, Gabor Forgacs, Sally Dickinson
- The longer term:
Philip Moriarty, Tanya Jones, Leonid Gavrilov
In addition, there will be at least twenty short talks selected from submitted abstracts, as well as poster sessions each evening. Authors of short talks and posters will, like the invited speakers, be invited to submit a paper summarising their presentation for the proceedings volume, which will be published in the high-impact journal Rejuvenation Research early in 2010.
Please note that registration fees are fully inclusive of accommodation and all meals. Those not requiring accommodation, journalists wishing to obtain free press passes (not including accommodation), and those who are unable to register using a credit card are asked to contact me by email (firstname.lastname@example.org).
I hope to welcome you to Cambridge in September!
Aubrey de Grey
Chief Science Officer, SENS Foundation
Editor-in-Chief, Rejuvenation Research
In case you missed it above, the biggest rockstar of all telomerase scientists, Maria Blasco, will be presenting. She is working closely with TA Sciences and Dr. Bill Andrews on an exciting new area of telomere biology that focuses on the effects of THE SHORTEST TELOMERES in the aging phenotype.
Good health to all,